Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio
July 06 2022 - 8:00AM
Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced continued
momentum in the commercialization of its HOLO Portal surgical
guidance system. The Company is pleased to report that Selvon St.
Clair, MD, PhD, and a board certified orthopaedic and spinal
surgeon at the Orthopaedic Institute of Ohio, performed his first
case with the HOLO Portal system.
HOLO Portal is the world’s first surgical guidance system to
incorporate AI and AR. This is the first clinical application of
Surgalign’s HOLO™ AI digital health platform. The system’s AI
processes intraoperative images to autonomously segment and label
the anatomy and plan patient-specific pedicle screw trajectories
that are approved by the surgeon. The HOLO Portal system uses AR to
overlay the segmented AI reconstruction over the patient’s actual
anatomy, providing real-time 3D visualization throughout the
surgical procedure. This AR display helps surgeons visualize
trajectories and guides surgical instruments.
“With previous technology the surgeon has had to process three
2D images on a monitor across the room increasing the cognitive
load on the surgeon in the case. With the HOLO Portal system, the
AI anatomic segmentation displayed through AR provides a 3D
visualization within the surgical field. My first case was
seamless—easy to setup, and the crisp holographic image facilitated
precise screw positioning increasing my confidence in the system,”
said Dr. St. Clair, who completed his orthopedic surgery residency
at Cleveland Clinic and his spine fellowship at Emory University
School of Medicine Spine Center, GA.
Dr. Frank Fumich, also of the Orthopaedic Institute of Ohio,
added, “The system continues to impress me as well, but more
importantly, the technology will help patients by displaying key
guidance information within the surgical field with minimal
distractions. We look forward to utilizing the HOLO Portal surgical
guidance system as we continuously look for new and innovative ways
to improve patient outcomes.”
In January 2022, the Company received U.S. Food & Drug
Administration (FDA) 510(k) clearance for use of the HOLO Portal
system within lumbar spine procedures. The Company is currently
expanding the system’s limited market release and intends to ramp
up its site locations throughout the year. As cases are performed
and data is accumulated, the Company also intends to integrate new
applications on its platform to advance the quality of care and
improve outcomes for patients.
“Congratulations to Dr. St. Clair for completing the first
surgical case in Ohio with the Surgalign HOLO Portal system,” said
Terry Rich, President and CEO of Surgalign. “We couldn’t be more
pleased with the performance of our HOLO Portal system to date, and
the surgeon excitement generated by the technology is palpable. We
believe to be on the cusp of something special here at Surgalign
and look forward to bringing the benefit of HOLO Portal technology
to thousands more patients to come.”
About Surgalign Holdings, Inc.Surgalign
Holdings, Inc. is a global medical technology company committed to
the promise of digital health to drive transformation across the
surgical landscape. Uniquely aligned and resourced to advance the
standard of care, the Company is building technologies physicians
and other health providers will look to for what is truly possible
for their patients. Surgalign is focused on developing solutions
that predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in more
than 50 countries worldwide through an expanding network of top
independent distributors. Surgalign is headquartered in Deerfield,
IL, with commercial, innovation and design centers in San Diego,
CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Learn more
at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking StatementThis press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on management’s current
expectations, estimates and projections about our products,
company, and industry, our management's beliefs, and certain
assumptions made by our management. Words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
and other variations of such words and similar expressions are
intended to identify such forward-looking statements.
Forward-looking statements include statements regarding the
features, capabilities and benefits of the HOLO Portal system.
These statements are not guarantees of future performance and are
subject to risks and uncertainties, including the risks described
in our public filings with the U.S. Securities and Exchange
Commission (SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting Surgalign's website
at www.surgalign.com or the SEC's website
at www.sec.gov.
Investor and Media Contact: Glenn Wiener
gwiener@gwcco.com+1 917 887 8434 |
Surgalign Contact:Kristine
Simmonsksimmons@surgalign.com+1 619 206 4648 |
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2024 to May 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From May 2023 to May 2024